Sri Chavadi Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.99 M
- Company Age 29 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.99 Cr
- Revenue Growth -10.08%
- Profit Growth -65.20%
- Ebitda -82.77%
- Net Worth 4.88%
- Total Assets -26.02%
About Sri Chavadi Pharma
Sri Chavadi Pharma Private Limited (SCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 1996 and has a history of 29 years. Its registered office is in Kottur, Andhra Pradesh, Telangana.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.99 M.
The company has closed loans amounting to ₹3.99 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sailaja Devireddy, Devireddy Deepna, Dileep Bakireddy, and One other member serve as directors at the Company.
Company Details
- Location Kottur, Andhra Pradesh, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110TG1996PTC023074
- Company No.
023074
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Chavadi Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dileep Bakireddy ![]() | Managing Director | 12-Apr-2021 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sailaja Devireddy ![]() | Director | 01-Feb-1996 | Current |
Devireddy Deepna ![]() | Director | 30-Sep-2014 | Current |
Devereddy Reddy ![]() | Director | 30-Sep-2014 | Current |
Financial Performance of Sri Chavadi Pharma.
Sri Chavadi Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.08% decrease. The company also saw a substantial fall in profitability, with a 65.2% decrease in profit. The company's net worth moved up by a moderate rise of 4.88%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Chavadi Pharma?
In 2021, Sri Chavadi Pharma had a promoter holding of 86.84% and a public holding of 13.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹39.85 M
Charges Breakdown by Lending Institutions
- Andhra Pradesh State Financial Corporation : 1.65 Cr
- State Bank Of Hyderabad : 1.50 Cr
- State Bank Of India : 0.84 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Apr 2014 | Andhra Pradesh State Financial Corporation | ₹6.50 M | Satisfied |
07 Sep 2010 | Andhra Pradesh State Financial Corporation | ₹1.00 Cr | Satisfied |
06 Aug 2004 | State Bank Of Hyderabad | ₹1.50 Cr | Satisfied |
03 Feb 1997 | State Bank Of India | ₹8.35 M | Satisfied |
How Many Employees Work at Sri Chavadi Pharma?
Sri Chavadi Pharma has a workforce of 27 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sri Chavadi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Chavadi Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.